Nationwide cloud-based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion
- PMID: 30880283
- PMCID: PMC6853800
- DOI: 10.1183/13993003.02243-2018
Nationwide cloud-based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion
Abstract
Multidisciplinary discussion (MDD) requiring close communication between specialists (clinicians, radiologists and pathologists) is the gold standard for the diagnosis of idiopathic interstitial pneumonias (IIPs). However, MDD by specialists is not always feasible because they are often separated by time and location. An online database would facilitate data sharing and MDD. Our aims were to develop a nationwide cloud-based integrated database containing clinical, radiological and pathological data of patients with IIPs along with a web-based MDD system, and to validate the diagnostic utility of web-based MDD in IIPs.Clinical data, high-resolution computed tomography images and lung biopsy slides from patients with IIPs were digitised and uploaded to separate servers to develop a cloud-based integrated database. Web-based MDD was performed using the database and video-conferencing to reach a diagnosis.Clinical, radiological and pathological data of 524 patients in 39 institutions were collected, uploaded and incorporated into the cloud-based integrated database. Subsequently, web-based MDDs with a pulmonologist, radiologist and pathologist using the database and video-conferencing were successfully performed for the 465 cases with adequate data. Overall, the web-based MDD changed the institutional diagnosis in 219 cases (47%). Notably, the MDD diagnosis yielded better prognostic separation among the IIPs than did the institutional diagnosis.This is the first study of developing a nationwide cloud-based integrated database containing clinical, radiological and pathological data for web-based MDD in patients with IIPs. The database and the web-based MDD system that we built made MDD more feasible in practice, potentially increasing accurate diagnosis of IIPs.
Copyright ©ERS 2019.
Conflict of interest statement
Conflict of interest: T. Fujisawa has nothing to disclose. Conflict of interest: K. Mori has nothing to disclose. Conflict of interest: M. Mikamo has nothing to disclose. Conflict of interest: T. Ohno has nothing to disclose. Conflict of interest: K. Kataoka has nothing to disclose. Conflict of interest: C. Sugimoto has nothing to disclose. Conflict of interest: H. Kitamura has nothing to disclose. Conflict of interest: N. Enomoto has nothing to disclose. Conflict of interest: R. Egashira has nothing to disclose. Conflict of interest: H. Sumikawa has nothing to disclose. Conflict of interest: T. Iwasawa has nothing to disclose. Conflict of interest: S. Matsushita has nothing to disclose. Conflict of interest: H. Sugiura receives honoraria for consultancy services from Ono Pharmaceutical Co., Ltd, Bristol-Myers Squibb KK and MSD KK. Conflict of interest: M. Hashisako has nothing to disclose. Conflict of interest: T. Tanaka has nothing to disclose. Conflict of interest: Y. Terasaki has nothing to disclose. Conflict of interest: S. Kunugi has nothing to disclose. Conflict of interest: M. Kitani has nothing to disclose. Conflict of interest: R. Okuda has nothing to disclose. Conflict of interest: Y. Horiike has nothing to disclose. Conflict of interest: Y. Enomoto has nothing to disclose. Conflict of interest: H. Yasui has nothing to disclose. Conflict of interest: H. Hozumi has nothing to disclose. Conflict of interest: Y. Suzuki has nothing to disclose. Conflict of interest: Y. Nakamura has nothing to disclose. Conflict of interest: J. Fukuoka has nothing to disclose. Conflict of interest: T. Johkoh has nothing to disclose. Conflict of interest: Y. Kondoh has nothing to disclose. Conflict of interest: T. Ogura has nothing to disclose. Conflict of interest: Y. Inoue reports fees for advisory board work and lecturing from Boehringer Ingelheim, outside the submitted work. Conflict of interest: Y. Hasegawa has nothing to disclose. Conflict of interest: N. Inase has nothing to disclose. Conflict of interest: S. Homma has nothing to disclose. Conflict of interest: T. Suda has nothing to disclose.
Figures
References
-
- American Thoracic Society , European Respiratory Society American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002; 165: 277–304. - PubMed
-
- Raghu G, Remy-Jardin M, Myers JL, et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 2018; 198: e44–e68. - PubMed
-
- Bjoraker JA, Ryu JH, Edwin MK, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 157: 199–203. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources